1
|
O'Brien JA, Jonassaint CR, Parchuri E, Lalama CM, Badawy SM, Hamm ME, Stinson JN, Lalloo C, Carroll CP, Saraf SL, Gordeuk VR, Cronin RM, Shah N, Lanzkron SM, Liles D, Trimnell C, Bailey L, Lawrence R, Saint Jean L, DeBaun M, De Castro LM, Palermo TM, Abebe KZ. The use of abstract animations and a graphical body image for assessing pain outcomes among adults with sickle cell disease. THE JOURNAL OF PAIN 2024; 26:104720. [PMID: 39447944 DOI: 10.1016/j.jpain.2024.104720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 09/24/2024] [Accepted: 10/18/2024] [Indexed: 10/26/2024]
Abstract
Painimation, a novel digital pain assessment tool, allows patients to communicate their pain quality, intensity, and location using abstract animations (painimations) and a paintable body image. This study determined the construct validity of painimations and body image measures by testing correlations with validated pain outcomes in adults with sickle cell disease (SCD). Analyses used baseline data from a multisite randomized trial of 359 adults with SCD and chronic pain. Participants completed questionnaires on demographics, pain severity, frequency and interference, catastrophizing, opioid use, mood and quality of life, plus the Painimation app. Participants were categorized by selected painimations, and were split into groups based on the proportion of painted body image. Potential confounding was evaluated by age, gender, race, education, disability, site, depression, and anxiety. The 'shooting' painimation was strongly associated with daily pain intensity, pain interference, frequency, and severity. 'Electrifying' was associated with daily pain and opioid misuse, while greater body area in pain correlated with worse outcomes across all pain measures. Both painimations and body image measures correlated with validated pain outcomes, quality of life and mental health measures. This demonstrates animations and body image data can assess SCD pain severity, potentially with more accuracy than a 0-10 scale. Future research will explore whether Painimation can differentiate biological and psychosocial pain components. PERSPECTIVE: This article presents the preliminary construct validity of Painimation in SCD by examining the associations of "painimations" and body area image data with daily e-diary and traditional self-report pain outcomes.
Collapse
Affiliation(s)
- Julia A O'Brien
- Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA
| | | | - Ektha Parchuri
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| | | | - Sherif M Badawy
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - Megan E Hamm
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| | - Jennifer N Stinson
- Lawrence S. Bloomberg, Faculty of Nursing, University of Toronto, Toronto, ON, Canada; Child Health Evaluation Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Institute for Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada
| | - Chitra Lalloo
- Child Health Evaluation Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Institute for Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada
| | - C Patrick Carroll
- Johns Hopkins Sickle Cell Center for Adults, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Santosh L Saraf
- Sickle Cell Center, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
| | - Victor R Gordeuk
- Sickle Cell Center, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
| | - Robert M Cronin
- Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
| | - Nirmish Shah
- Sickle Cell Transition Program, Division of Hematology, Division of Pediatric Hematology/Oncology, Duke University, Durham, NC, USA
| | - Sophie M Lanzkron
- Johns Hopkins Sickle Cell Center for Adults, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Darla Liles
- Department of Internal Medicine, East Carolina University, Greenville, NC, USA
| | | | | | - Raymona Lawrence
- Jiann Ping Hsu College of Public Health, Georgia Southern University, Savannah, GA, USA
| | - Leshana Saint Jean
- Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Michael DeBaun
- Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Laura M De Castro
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| | - Tonya M Palermo
- Department of Anesthesiology & Pain Medicine, University of Washington, and Seattle Children's Research Institute, Seattle, WA, USA
| | - Kaleab Z Abebe
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|